Corrigendum

Abstract

Tashkin DP, Doherty DE, Kerwin E, Matiz-Bueno CE, Knorr B, Shekar T, Banerjee S, Staudinger H. Efficacy and safety of a fixed-dose combination of mometasone furoate and formoterol fumarate in subjects with moderate to very severe COPD: results from a 52-week Phase III trial. Int J Chron Obstruct Pulmon Dis. 2012;7:43–55. In Table 4, the value at column 5, row 15 should have been 4 instead of 2. The corrected table is below. Table 4 Summary of treatment-emergent adverse events Number of subjects (%) MF/F 200/10 μg bid (n = 207) MF/F 400/10 μg bid (n = 217) MF 400 μg bid (n = 210) F 10 μg bid (n = 209) Placebo bid (n = 212) Treatment period (weeks 1–26)  Any AE 62 (30.0) 57 (26.3) 62 (29.5) 70 (33.5) 67 (31.6)  Severe or life-threatening AEs 6 (2.9) 9 (4.1) 15 (7.1) 16 (7.7) 12 (5.7)  Life-threatening AEs 0 4 (1.8) 4 (1.9) 4 (1.9) 3 (1.4)  Serious AEs 8 (3.9) 16 (7.4) 15 (7.1) 17 (8.1) 12 (5.7)  Discontinuations due to AEs 2 (1.0) 10 (4.6) 9 (4.3) 6 (2.9) 8 (3.8)  Deaths 1 (0.4) 1 (0.4) 3 (1.4) 3 (1.4) 1 (0.4)  Pneumonia 1 (0.5) 2 (0.9) 0 2 (1.0) 1 (0.5)  Treatment-related AEs 9 (4.3) 13 (6.0) 12 (5.7) 15 (7.2) 10 (4.7) Treatment period + safety extension (weeks 1–52)  Any AE 78 (37.7) 78 (35.9) 86 (41.07) 88 (42.1)  Severe or life-threatening AEs 7 (3.4) 21 (9.7) 19 (9.0) 24 (11.5)  Life-threatening AEs 1 (0.5) 6 (2.8) 4 (1.9) 6 (2.9)  Serious AEs 13 (6.3) 29 (13.4) 22 (10.5) 29 (13.9)  Discontinuations due to AEs 4 (1.9) 14 (6.5) 13 (6.2) 11 (5.3)  Deaths 1 (0.4) 3 (1.3) 3 (1.4) 8 (3.8)  Pneumonia 1 (0.5) 4 (1.8) 2 (1.0) 4 (1.9)  Treatment-related AEs 12 (5.8) 18 (8.3) 15 (7.1) 17 (8.1) Abbreviations: AE, adverse event; bid, twice daily; F, formoterol; MF, mometasone furoate; MF/F, mometasone furoate/formoterol fixed-dose combination.

Journal

Journal ID (nlm-ta): Int J Chron Obstruct Pulmon Dis

Journal ID (iso-abbrev): Int J Chron Obstruct Pulmon Dis

Journal ID (publisher-id): International Journal of COPD

Title: International Journal of Chronic Obstructive Pulmonary Disease

Publisher: Dove Medical Press

ISSN (Print): 1176-9106

ISSN (Electronic): 1178-2005

Publication date Collection: 2012

Publication date (Print): 2012

Publication date (Electronic): 16 November 2012

Volume: 7

Page: 765

Article

Publisher ID: copd-7-765

DOI: 10.2147/COPD.S32106

PMC ID: 3508664

Copyright statement: © 2012 Tashkin et al, publisher and licensee Dove Medical Press Ltd.

License:

This is an Open Access article which permits unrestricted noncommercial use, provided the original work is properly cited.

Categories

Subject: Corrigendum